Business ❯Pharmaceuticals

Investment

Manufacturing Job Creation Public Investment Government Funding International Business Research and Development Clinical Trials U.S. Operations Life Sciences Dublin Development

AstraZeneca Pledges $50 Billion for U.S. Manufacturing and R&D Expansion

Company executives say the investment will shield U.S. operations from potential import tariffs.

UK Finalizes £1bn BioNTech Deal to Advance mRNA Cancer Vaccines and AI Research

Roche Announces $50 Billion U.S. Investment to Expand Manufacturing and R&D

Roche Announces $50 Billion U.S. Investment to Expand R&D and Manufacturing

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence

AstraZeneca Cancels £450m UK Vaccine Plant Expansion Over Funding Dispute

AstraZeneca Cancels £450m UK Vaccine Plant Investment